Afya Limited (NASDAQ:AFYA) Stock Position Raised by State Street Corp

State Street Corp increased its holdings in shares of Afya Limited (NASDAQ:AFYA) by 118.2% during the 3rd quarter, Holdings Channel.com reports. The fund owned 73,098 shares of the company’s stock after buying an additional 39,592 shares during the period. State Street Corp’s holdings in Afya were worth $1,248,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently bought and sold shares of the business. Quarry LP bought a new position in shares of Afya during the third quarter valued at approximately $75,000. Point72 Asset Management L.P. acquired a new position in Afya during the 3rd quarter valued at approximately $842,000. Centiva Capital LP acquired a new position in Afya during the 3rd quarter valued at approximately $213,000. Erste Asset Management GmbH bought a new position in Afya during the 3rd quarter worth $822,000. Finally, PDT Partners LLC acquired a new stake in Afya in the third quarter worth $481,000. Institutional investors own 88.02% of the company’s stock.

Afya Stock Performance

AFYA opened at $15.63 on Friday. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51. The business’s 50 day moving average is $16.40 and its 200-day moving average is $16.89. The stock has a market cap of $1.46 billion, a PE ratio of 12.60, a price-to-earnings-growth ratio of 0.33 and a beta of 0.89. Afya Limited has a twelve month low of $14.52 and a twelve month high of $22.48.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group started coverage on shares of Afya in a report on Tuesday, December 3rd. They set a “sell” rating and a $16.00 price target for the company.

Afya Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.